Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

This journal supports open access


Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne


Become EABM
Become Reviewer

Meet Our Regional Editor free to download

Volume:18   Issue: 9
Pp: 1219-1219
Patrick Dallemagne
DOI: 10.2174/187152061809181207143928

Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?

Volume:18   Issue: 9
Pp: 1220-1227
F. Caponigro, F. Ionna, G. Della Vittoria Scarpati, F. Longo, R. Addeo, R. Manzo, P. Muto, S. Pisconti, L. Leopaldi and F. Perri*
DOI: 10.2174/1871520618666180411110036

Indazole Derivatives: Promising Anti-tumor Agents

Volume:18   Issue: 9
Pp: 1228-1234
Yichao Wan*, Shengzhuo He, Wei Li and Zilong Tang
DOI: 10.2174/1871520618666180510113822

From Biology to Therapy: Improvements of Therapeutic Options in Lung Cancer

Volume:18   Issue: 9
Pp: 1235-1240
Luigi Formisano, Valerie M. Jansen, Roberta Marciano and Roberto Bianco*
DOI: 10.2174/1871520617666170912123416

Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer

Volume:18   Issue: 9
Pp: 1241-1251
Fengquan Chen, Chunxi Liu, Jian Zhang, Wenfang Xu* and Yingjie Zhang*
DOI: 10.2174/1871521409666170412123500

PLK1 Inhibition Radiosensitizes Breast Cancer Cells, but Shows Low Efficacy as Monotherapy or in Combination with other Cytotoxic Drugs

Volume:18   Issue: 9
Pp: 1252-1257
María Sol Brassesco*, Julia Alejandra Pezuk, Karina Bezerra Salomão, Gabriela Molinari Roberto, Carlos Alberto Scrideli and Luiz Gonzaga Tone
DOI: 10.2174/1871520618666180228155435

Suppression of the Viability and Proliferation of HepG2 Hepatocellular Carcinoma Cell Line by Konjac Glucomannan

Volume:18   Issue: 9
Pp: 1258-1266
Sakunie Sawai, Mas Sahidayana Mohktar*, Wan Kamarul Zaman Wan Safwani and Thamil Selvee Ramasamy
DOI: 10.2174/1871520618666180307143229

Ultrasound Promoted Green Synthesis, Docking Study of Indole Spliced Thiadiazole, α-amino Phosphonates as Anticancer Agents and Antityrosinase Agents

Volume:18   Issue: 9
Pp: 1267-1280
Annapratima G. Nikalje*, Pramod A. Gawhane, Shailee V. Tiwari, Jaiprakash N. Sangshetti and Manoj G. Damale
DOI: 10.2174/1871520618666180417163226

68Ga-labeled HBED-CC Variant of uPAR Targeting Peptide AE105 Compared with 68Ga-NODAGA-AE105

Volume:18   Issue: 9
Pp: 1289-1294
Kusum Vats, Rohit Sharma, Haladhar D. Sarma, Drishty Satpati* and Ashutosh Dash
DOI: 10.2174/1871520618666180316152618

99mTc-(tricine)-HYNIC-Lys-FROP Peptide for Breast Tumor Targeting

Volume:18   Issue: 9
Pp: 1295-1302
Sajjad Ahmadpour, Zohreh Noaparast, Seyed Mohammad Abedi and Seyed Jalal Hosseinimehr*
DOI: 10.2174/1871520618666180307142027

DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma

Volume:18   Issue: 9
Pp: 1323-1329
Gabriela Molinari Roberto, Helder Henrique Paiva, Lucas Eduardo Botelho de Souza, Julia Alejandra Pezuk, Gabriela Maciel Vieira, Harley Francisco de Oliveira, Kazuo Umezawa, Luiz Gonzaga Tone and María Sol Brassesco*
DOI: 10.2174/1871520618666180423105740

Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction

Volume:18   Issue: 9
Pp: 1330-1337
Wided Kebsa, Mesbah Lahouel*, Hassiba Rouibah, Malek Zihlif, Mamoun Ahram, Bashaer Abu-Irmaileh, Ebtihal Mustafa, Hamzeh J. Al-Ameer and Mohammad Al Shhab
DOI: 10.2174/1871520618666180808100800

A Comparison of Fucoidan Conjugated to Paclitaxel and Curcumin for the Dual Delivery of Cancer Therapeutic Agents

Volume:18   Issue: 9
Pp: 1349-1355
Nam H. Phan, Thao T. Ly, Minh N. Pham, Thinh D. Luu, Toi V. Vo, Phuong H.L. Tran and Thao T.D. Tran*
DOI: 10.2174/1871520617666171121125845